세계의 대사체학 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2034년)

Metabolomics Market - Scope of Report

TMR's report on the global metabolomics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global metabolomics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global metabolomics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the metabolomics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global metabolomics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global metabolomics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global metabolomics market.

The report delves into the competitive landscape of the global metabolomics market. Key players operating in the global metabolomics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global metabolomics market profiled in this report.

Key Questions Answered in Global metabolomics Market Report:

• What is the sales/revenue generated by metabolomics across all regions during the forecast period?
• What are the opportunities in the global metabolomics market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Metabolomics Market - Research Objectives and Research Approach

The comprehensive report on the global metabolomics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global metabolomics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global metabolomics market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Metabolomics Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Metabolomics Market Analysis and Forecasts, 2020-2034
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. Recent Advancements in Metabolomics Industry
• 5.2. Patent Analysis
• 5.3. Regulatory Landscape for Venous Stents in Key Regions / Countries
• 5.4. Key Industry Events (Product Approvals, Partnerships, and Collaborations)
• 5.5. Impact of COVID-19 Pandemic

6. Global Metabolomics Market Analysis and Forecasts, By Product and Service Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Product and Service Type, 2020-2034
  • 6.3.1. Metabolomics Instruments
    • 6.3.1.1. Separation Tools
      • 6.3.1.1.1. High Performance Liquid Chromatography
      • 6.3.1.1.2. Gas Chromatography
      • 6.3.1.1.3. Ultra Performance Liquid Chromatography
      • 6.3.1.1.4. Capillary Electrophoresis
    • 6.3.1.2. Detection Tools
      • 6.3.1.2.1. Mass Spectrometry
      • 6.3.1.2.2. Nuclear Magnetic Resonance Spectroscopy
      • 6.3.1.2.3. Surface-based Mass Analysis
  • 6.3.2. Bioinformatics Tools and Services
    • 6.3.2.1. Bioinformatics Services
    • 6.3.2.2. Bioinformatics Tools and Databases
• 6.4. Market Attractiveness By Product and Service Type

7. Global Metabolomics Market Analysis and Forecasts, By Application

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Application, 2020-2034
  • 7.3.1. Biomarker Discovery
  • 7.3.2. Drug Discovery
  • 7.3.3. Toxicology Testing
  • 7.3.4. Nutrigenomics
  • 7.3.5. Personalized Medicine
  • 7.3.6. Others
• 7.4. Market Attractiveness By Application

8. Global Metabolomics Market Analysis and Forecasts, By Indication

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Indication, 2020-2034
  • 8.3.1. Oncological Disorders
  • 8.3.2. Cardiovascular Disorders
  • 8.3.3. Neurological Disorders
  • 8.3.4. Metabolic Disorders
  • 8.3.5. Others
• 8.4. Market Attractiveness By Indication

9. Global Metabolomics Market Analysis and Forecasts, By End-user

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By End-user, 2020-2034
  • 9.3.1. Academic and Research Institutes
  • 9.3.2. Pharmaceutical and Biotechnology Companies
  • 9.3.3. Contract Research Organizations
• 9.4. Market Attractiveness By End-user

10. Global Metabolomics Market Analysis and Forecasts, By Region

• 10.1. Key Findings
• 10.2. Market Value Forecast By Region
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness By Country/Region

11. North America Metabolomics Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Product and Service Type, 2020-2034
  • 11.2.1. Metabolomics Instruments
    • 11.2.1.1. Separation Tools
      • 11.2.1.1.1. High Performance Liquid Chromatography
      • 11.2.1.1.2. Gas Chromatography
      • 11.2.1.1.3. Ultra Performance Liquid Chromatography
      • 11.2.1.1.4. Capillary Electrophoresis
    • 11.2.1.2. Detection Tools
      • 11.2.1.2.1. Mass Spectrometry
      • 11.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
      • 11.2.1.2.3. Surface-based Mass Analysis
  • 11.2.2. Bioinformatics Tools and Services
    • 11.2.2.1. Bioinformatics Services
    • 11.2.2.2. Bioinformatics Tools and Databases
• 11.3. Market Value Forecast By Application, 2020-2034
  • 11.3.1. Biomarker Discovery
  • 11.3.2. Drug Discovery
  • 11.3.3. Toxicology Testing
  • 11.3.4. Nutrigenomics
  • 11.3.5. Personalized Medicine
  • 11.3.6. Others
• 11.4. Market Value Forecast By Indication, 2020-2034
  • 11.4.1. Oncological Disorders
  • 11.4.2. Cardiovascular Disorders
  • 11.4.3. Neurological Disorders
  • 11.4.4. Metabolic Disorders
  • 11.4.5. Others
• 11.5. Market Value Forecast By End-user, 2020-2034
  • 11.5.1. Academic and Research Institutes
  • 11.5.2. Pharmaceutical and Biotechnology Companies
  • 11.5.3. Contract Research Organizations
• 11.6. Market Value Forecast By Country, 2020-2034
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Product and Service Type
  • 11.7.2. By Application
  • 11.7.3. By Indication
  • 11.7.4. By End-user
  • 11.7.5. By Country

12. Europe Metabolomics Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Product and Service Type, 2020-2034
  • 12.2.1. Metabolomics Instruments
    • 12.2.1.1. Separation Tools
      • 12.2.1.1.1. High Performance Liquid Chromatography
      • 12.2.1.1.2. Gas Chromatography
      • 12.2.1.1.3. Ultra Performance Liquid Chromatography
      • 12.2.1.1.4. Capillary Electrophoresis
    • 12.2.1.2. Detection Tools
      • 12.2.1.2.1. Mass Spectrometry
      • 12.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
      • 12.2.1.2.3. Surface-based Mass Analysis
  • 12.2.2. Bioinformatics Tools and Services
    • 12.2.2.1. Bioinformatics Services
    • 12.2.2.2. Bioinformatics Tools and Databases
• 12.3. Market Value Forecast By Application, 2020-2034
  • 12.3.1. Biomarker Discovery
  • 12.3.2. Drug Discovery
  • 12.3.3. Toxicology Testing
  • 12.3.4. Nutrigenomics
  • 12.3.5. Personalized Medicine
  • 12.3.6. Others
• 12.4. Market Value Forecast By Indication, 2020-2034
  • 12.4.1. Oncological Disorders
  • 12.4.2. Cardiovascular Disorders
  • 12.4.3. Neurological Disorders
  • 12.4.4. Metabolic Disorders
  • 12.4.5. Others
• 12.5. Market Value Forecast By End-user, 2020-2034
  • 12.5.1. Academic and Research Institutes
  • 12.5.2. Pharmaceutical and Biotechnology Companies
  • 12.5.3. Contract Research Organizations
• 12.6. Market Value Forecast By Country / Sub-region, 2020-2034
  • 12.6.1. Germany
  • 12.6.2. U.K.
  • 12.6.3. France
  • 12.6.4. Spain
  • 12.6.5. Italy
  • 12.6.6. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Product and Service Type
  • 12.7.2. By Application
  • 12.7.3. By Indication
  • 12.7.4. By End-user
  • 12.7.5. By Country / Sub-region

13. Asia Pacific Metabolomics Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Product and Service Type, 2020-2034
  • 13.2.1. Metabolomics Instruments
    • 13.2.1.1. Separation Tools
      • 13.2.1.1.1. High Performance Liquid Chromatography
      • 13.2.1.1.2. Gas Chromatography
      • 13.2.1.1.3. Ultra Performance Liquid Chromatography
      • 13.2.1.1.4. Capillary Electrophoresis
    • 13.2.1.2. Detection Tools
      • 13.2.1.2.1. Mass Spectrometry
      • 13.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
      • 13.2.1.2.3. Surface-based Mass Analysis
  • 13.2.2. Bioinformatics Tools and Services
    • 13.2.2.1. Bioinformatics Services
    • 13.2.2.2. Bioinformatics Tools and Databases
• 13.3. Market Value Forecast By Application, 2020-2034
  • 13.3.1. Biomarker Discovery
  • 13.3.2. Drug Discovery
  • 13.3.3. Toxicology Testing
  • 13.3.4. Nutrigenomics
  • 13.3.5. Personalized Medicine
  • 13.3.6. Others
• 13.4. Market Value Forecast By Indication, 2020-2034
  • 13.4.1. Oncological Disorders
  • 13.4.2. Cardiovascular Disorders
  • 13.4.3. Neurological Disorders
  • 13.4.4. Metabolic Disorders
  • 13.4.5. Others
• 13.5. Market Value Forecast By End-user, 2020-2034
  • 13.5.1. Academic and Research Institutes
  • 13.5.2. Pharmaceutical and Biotechnology Companies
  • 13.5.3. Contract Research Organizations
• 13.6. Market Value Forecast By Country / Sub-region, 2020-2034
  • 13.6.1. China
  • 13.6.2. Japan
  • 13.6.3. India
  • 13.6.4. Australia & New Zealand
  • 13.6.5. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Product and Service Type
  • 13.7.2. By Application
  • 13.7.3. By Indication
  • 13.7.4. By End-user
  • 13.7.5. By Country / Sub-region

14. Latin America Metabolomics Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Product and Service Type, 2020-2034
  • 14.2.1. Metabolomics Instruments
    • 14.2.1.1. Separation Tools
      • 14.2.1.1.1. High Performance Liquid Chromatography
      • 14.2.1.1.2. Gas Chromatography
      • 14.2.1.1.3. Ultra Performance Liquid Chromatography
      • 14.2.1.1.4. Capillary Electrophoresis
    • 14.2.1.2. Detection Tools
      • 14.2.1.2.1. Mass Spectrometry
      • 14.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
      • 14.2.1.2.3. Surface-based Mass Analysis
  • 14.2.2. Bioinformatics Tools and Services
    • 14.2.2.1. Bioinformatics Services
    • 14.2.2.2. Bioinformatics Tools and Databases
• 14.3. Market Value Forecast By Application, 2020-2034
  • 14.3.1. Biomarker Discovery
  • 14.3.2. Drug Discovery
  • 14.3.3. Toxicology Testing
  • 14.3.4. Nutrigenomics
  • 14.3.5. Personalized Medicine
  • 14.3.6. Others
• 14.4. Market Value Forecast By Indication, 2020-2034
  • 14.4.1. Oncological Disorders
  • 14.4.2. Cardiovascular Disorders
  • 14.4.3. Neurological Disorders
  • 14.4.4. Metabolic Disorders
  • 14.4.5. Others
• 14.5. Market Value Forecast By End-user, 2020-2034
  • 14.5.1. Academic and Research Institutes
  • 14.5.2. Pharmaceutical and Biotechnology Companies
  • 14.5.3. Contract Research Organizations
• 14.6. Market Value Forecast By Country / Sub-region, 2020-2034
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Product and Service Type
  • 14.7.2. By Application
  • 14.7.3. By Indication
  • 14.7.4. By End-user
  • 14.7.5. By Country / Sub-region

15. Middle East & Africa Metabolomics Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Product and Service Type, 2020-2034
  • 15.2.1. Metabolomics Instruments
    • 15.2.1.1. Separation Tools
      • 15.2.1.1.1. High Performance Liquid Chromatography
      • 15.2.1.1.2. Gas Chromatography
      • 15.2.1.1.3. Ultra Performance Liquid Chromatography
      • 15.2.1.1.4. Capillary Electrophoresis
    • 15.2.1.2. Detection Tools
      • 15.2.1.2.1. Mass Spectrometry
      • 15.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
      • 15.2.1.2.3. Surface-based Mass Analysis
  • 15.2.2. Bioinformatics Tools and Services
    • 15.2.2.1. Bioinformatics Services
    • 15.2.2.2. Bioinformatics Tools and Databases
• 15.3. Market Value Forecast By Application, 2020-2034
  • 15.3.1. Biomarker Discovery
  • 15.3.2. Drug Discovery
  • 15.3.3. Toxicology Testing
  • 15.3.4. Nutrigenomics
  • 15.3.5. Personalized Medicine
  • 15.3.6. Others
• 15.4. Market Value Forecast By Indication, 2020-2034
  • 15.4.1. Oncological Disorders
  • 15.4.2. Cardiovascular Disorders
  • 15.4.3. Neurological Disorders
  • 15.4.4. Metabolic Disorders
  • 15.4.5. Others
• 15.5. Market Value Forecast By End-user, 2020-2034
  • 15.5.1. Academic and Research Institutes
  • 15.5.2. Pharmaceutical and Biotechnology Companies
  • 15.5.3. Contract Research Organizations
• 15.6. Market Value Forecast By Country / Sub-region, 2020-2034
  • 15.6.1. GCC Countries
  • 15.6.2. South Africa
  • 15.6.3. Rest of Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Product and Service Type
  • 15.7.2. By Application
  • 15.7.3. By Indication
  • 15.7.4. By End-user
  • 15.7.5. By Country / Sub-region

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 16.2. Company Profiles
  • 16.2.1. Waters Corporation
    • 16.2.1.1. Company Overview
    • 16.2.1.2. Financial Overview
    • 16.2.1.3. Product Portfolio
    • 16.2.1.4. Business Strategies
    • 16.2.1.5. Recent Developments
  • 16.2.2. Agilent Technologies, Inc.
    • 16.2.2.1. Company Overview
    • 16.2.2.2. Financial Overview
    • 16.2.2.3. Product Portfolio
    • 16.2.2.4. Business Strategies
    • 16.2.2.5. Recent Developments
  • 16.2.3. Thermo Fisher Scientific Inc.
    • 16.2.3.1. Company Overview
    • 16.2.3.2. Financial Overview
    • 16.2.3.3. Product Portfolio
    • 16.2.3.4. Business Strategies
    • 16.2.3.5. Recent Developments
  • 16.2.4. Danaher Corporation
    • 16.2.4.1. Company Overview
    • 16.2.4.2. Financial Overview
    • 16.2.4.3. Product Portfolio
    • 16.2.4.4. Business Strategies
    • 16.2.4.5. Recent Developments
  • 16.2.5. Bruker Corporation
    • 16.2.5.1. Company Overview
    • 16.2.5.2. Financial Overview
    • 16.2.5.3. Product Portfolio
    • 16.2.5.4. Business Strategies
    • 16.2.5.5. Recent Developments
  • 16.2.6. PerkinElmer
    • 16.2.6.1. Company Overview
    • 16.2.6.2. Financial Overview
    • 16.2.6.3. Product Portfolio
    • 16.2.6.4. Business Strategies
    • 16.2.6.5. Recent Developments
  • 16.2.7. Merck KGaA
    • 16.2.7.1. Company Overview
    • 16.2.7.2. Financial Overview
    • 16.2.7.3. Product Portfolio
    • 16.2.7.4. Business Strategies
    • 16.2.7.5. Recent Developments
  • 16.2.8. Metabolon, Inc.
    • 16.2.8.1. Company Overview
    • 16.2.8.2. Financial Overview
    • 16.2.8.3. Product Portfolio
    • 16.2.8.4. Business Strategies
    • 16.2.8.5. Recent Developments
  • 16.2.9. Afekta Technologies Ltd.
    • 16.2.9.1. Company Overview
    • 16.2.9.2. Financial Overview
    • 16.2.9.3. Product Portfolio
    • 16.2.9.4. Business Strategies
    • 16.2.9.5. Recent Developments
  • 16.2.10. Shimadzu Corporation
    • 16.2.10.1. Company Overview
    • 16.2.10.2. Financial Overview
    • 16.2.10.3. Product Portfolio
    • 16.2.10.4. Business Strategies
    • 16.2.10.5. Recent Developments